Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
2
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
2
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
andrew oxtoby
babies
biotech
blueprint medicines
breakup
bridge bio pharma
cancer
ceo
clinical hold
clinical study
What
medicine
2
×
approved
big
bio
bosley's
bosley’s
bridge
bucks
cancer
cas
ceo
crime
crispr
deeper
departure
dna
drug
editas
exit
fda
fingerprint
genetic
going
guiding
katrine
matter
moves
nd
new
oks
personnel
roundup
second
surprising
targets
time
tissues
tumor's
week
world
Language
Current search:
roche
×
medicine
×
" seattle top stories "
×
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues